481 studies found for:    "Squamous cell carcinoma of the head and neck"
Show Display Options
Rank Status Study
21 Recruiting Study of Dacomitinib With Radiotherapy With and Without Cisplatin in Patients With Squamous Cell Carcinoma of the Head and Neck
Condition: Squamous Cell Carcinoma of the Head and Neck
Interventions: Drug: Dacomitinib;   Radiation: Radiotherapy;   Drug: Cisplatin
22 Recruiting Re-irradiation With Fractionated Stereotactic Radiosurgery Plus Cetuximab in Patients With Recurrent Squamous Cell Carcinoma of the Head and Neck
Condition: Squamous Cell Carcinoma of the Head and Neck
Intervention: Other: Cetuximab and stereotactic radiosurgery
23 Recruiting Study Comparing Two Treatments in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
Condition: Squamous Cell Carcinoma of the Head and Neck
Interventions: Drug: Cabazitaxel;   Drug: Methotrexate
24 Suspended A Study of AT-101 in Combination With Docetaxel in Squamous Cell Carcinoma Of The Head and Neck
Condition: Squamous Cell Carcinoma of the Head and Neck (SCCHN)
Interventions: Drug: AT-101;   Drug: Docetaxel
25 Active, not recruiting
Has Results
Cetuximab With Radiotherapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck in Chinese Subjects
Condition: Squamous Cell Carcinoma of the Head and Neck
Intervention: Biological: Cetuximab + concomitant boost radiotherapy
26 Completed
Has Results
Study of Cetuximab in Combination With Chemotherapy in Patients With Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck (SCCHN)
Condition: Squamous Cell Carcinoma of the Head and Neck
Interventions: Drug: Cetuximab;   Drug: Cisplatin/Carboplatin;   Drug: 5-Fluorouracil
27 Recruiting Research of Biomarkers of Activity and Efficacy of BIBW2992 in Untreated Non-metastatic HNSCC Patients
Condition: Carcinoma, Squamous Cell of Head and Neck
Intervention: Drug: Afatinib
28 Unknown  Assessment of Regional Response With PET-FDG in Advanced Head and Neck Squamous Cell Carcinoma
Condition: Head and Neck Squamous Cell Carcinoma
Intervention: Other: pet scan
29 Completed Proximal Molecular Effects of Concurrent Chemoradiotherapy on Head and Neck Squamous Cell Carcinoma
Condition: Head and Neck Squamous Cell Carcinoma
Intervention: Biological: the arachidonic acid and EGFR signaling pathways and their interaction in HNSCC tumorigenesis,
30 Recruiting Non Inferiority Trial of Standard RT Versus Hypofractionated Split Course in Elderly Vulnerable Patients With HNSCC
Condition: Head and Neck Squamous Cell Carcinoma
Interventions: Radiation: Standard RT;   Radiation: Hypofractionated RT
31 Completed Nimotuzumab in Combination With TPF(Cisplatin ,Fluorouracil and Docetaxel) for Head and Neck Squamous Cell Carcinoma
Condition: Head and Neck Squamous Cell Carcinoma
Interventions: Drug: Chemotherapy;   Drug: Nimotuzumab and Chemotherapy
32 Terminated Docetaxel and S-1 in Head and Neck Squamous Cell Carcinoma (HNSCC)
Condition: Head and Neck Squamous Cell Carcinoma
Interventions: Drug: docetaxel+CDDP;   Drug: docetaxel+S-1
33 Recruiting Randomised Phase II, Cetuximab in Combination With 5FU and Cisplatin or Carboplatin Versus Cetuximab in Combination With Paclitaxel and Carboplatin for Treatment of Patients With Metastatic Squamous Cell Carcinoma of the Head and Neck
Condition: Squamous Cell Carcinoma of the Head and Neck
Intervention: Drug: Cetuximab
34 Active, not recruiting Paclitaxel, Carboplatin and Cetuximab (PCC) Versus Cetuximab, Docetaxel, Cisplatin and Fluorouracil (C-TPF) in Previously Untreated Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma (HNSCC)
Condition: Head and Neck Squamous Cell Carcinoma
Interventions: Drug: Paclitaxel;   Drug: Carboplatin;   Drug: Cetuximab;   Drug: Docetaxel;   Drug: Cisplatin;   Drug: Fluorouracil;   Radiation: Radiotherapy (RT);   Other: Chemotherapy
35 Recruiting Pemetrexed as Salvage Treatment in Squamous Cell Carcinoma of Head and Neck
Condition: Squamous Cell Carcinoma of Head and Neck
Intervention: Drug: Pemetrexed
36 Active, not recruiting Study of DCA (Dichloroacetate) in Combination With Cisplatin and Definitive Radiation in Head and Neck Carcinoma
Condition: Squamous Cell Carcinoma of the Head and Neck
Interventions: Drug: DCA (dichloroacetate);   Drug: Placebo
37 Active, not recruiting Study of TARCEVA (Erlotinib) as Adjuvant Treatment for Locally Advanced Head and Neck Squamous Cell Carcinoma
Condition: Head and Neck Squamous Cell Carcinoma
Interventions: Drug: Erlotinib;   Drug: Erlotinib plus sulindac;   Drug: Placebo
38 Recruiting Docetaxel And Cisplatin With or Without Erlotinib For Metastatic Or Recurrent Squamous Cell Carcinoma Of Head And Neck
Conditions: Head and Neck Cancer;   Squamous Cell Carcinoma of the Head and Neck
Interventions: Drug: Cisplatin;   Drug: Docetaxel;   Drug: Erlotinib;   Other: Placebo;   Drug: Carboplatin
39 Recruiting Trial of Nivolumab vs Therapy of Investigator's Choice in Recurrent or Metastatic Head and Neck Carcinoma (CheckMate 141)
Condition: Squamous Cell Carcinoma of the Head and Neck
Interventions: Drug: Nivolumab;   Drug: Cetuximab;   Drug: Methotrexate;   Drug: Docetaxel
40 Recruiting Stereotactic Body Radiotherapy and Concurrent Cisplatin for Re-Irradiation of Unresectable, Recurrent Squamous Cell Carcinomas of Head and Neck
Condition: Squamous Cell Carcinoma of the Head and Neck
Interventions: Drug: Cisplatin;   Radiation: Stereotactic Body Radiation Therapy (SBRT)

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years